Bavarian Nordic Reports Positive Result from ongoing Phase 2 Trial Evaluating BN-Brachyury in Chordoma

    NEXT STORY
    Emergent BioSolutions kündigt FDA-Zulassung für Änderung bei Lagerbedingungen und Produktionsverlagerungen für seinen Cholera-Impfstoff an
    PREV STORY
    Montreal’s Four Leading Pediatric Institutions Begin Largest Collaboration in Canadian History to Help Children with Musculoskeletal Disorders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene to Present at Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

    RedHill has been granted the exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release ...

    author_avatar
    NASDAQ Market News

    ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer

    author_avatar
    NASDAQ Market News